Tag
pharmaceutical trials
-
•
Skyrocketing drug price is chance to examine manufacturing, FDA approval process
St. Louis Post-Dispatch reporter (and Midwest Health Journalism Program Fellow) Jim Doyle has put together a series of stories on KV…
-
•
Taking stock of big pharma in Canada
CBC and Radio-Canada have cooperated to produce a comprehensive look at the nation’s pharmaceutical industry, which centers on Montreal, Canada’s…
-
•
Barlett & Steele uncover chaos, peril of global drug industry
In Vanity Fair, Donald Barlett and James Steele have devoted more than 6,000 words to chronicling the gaping holes in…
-
•
Ethics professor takes on clinical trials, marketing
Writing for Mother Jones, University of Minnesota medical ethics professor Carl Elliott digs into the Dan Markingson story first covered…
-
•
Gays excluded from clinical trials
Thanks to an awards announcement from the National Lesbian & Gay Journalists Association, we just noticed Jen Colletta’s story in…
-
•
Journalist recounts the pressure of GSK clinical trial
In the wake of questions about GlaxoSmithKline’s Avandia clinic trials, the Austin American-Statesman‘s Ana Cantú talks about her own experience…
-
•
Foreign trial data used in 4/5 of approved drugs
FairWarning’s Lea Yu and The New York Times‘ Gardiner Harris drew our attention to a report from the HHS Office…
-
•
Study authors don’t always have access to raw data
John Fauber of the Milwaukee Journal Sentinel reports on outside authors of drug company-funded studies who do not have access…
-
•
BMJ wants raw data for all drug trials to be shared
Under the headline “We want raw data, now,” BMJ editor Fiona Godlee recounts the story of how BMJ had to…
-
•
How the pharma research ‘sausage’ is made
Reporting on Health’s William Heisel has posted the latest installment in his series highlighting the spiciest entries in the Drug…